Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Priyabrata Pattnaik
Advertisement
Priyabrata Pattnaik, PHD, is head of biologics operations-Asia Pacific, MilliporeSigma.
Articles by Priyabrata Pattnaik
Advertisement
Latest Updated Articles
Ensuring Viral Safety of Viral Vaccines and VectorsPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
